Catalog No.
FHD03610
Species reactivity
Human
Host species
Mouse
Isotype
IgG1, kappa
Clonality
Monoclonal
Conjugation
Unconjugated
Applications
FCM
Target
MIC2Y, E2 antigen, MIC2X, 12E7, Protein MIC2, CD99 antigen, MIC2, T-cell surface glycoprotein E2, CD99
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P14209
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
12E7#
Note
For research use only.
CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts., PMID:31510956
Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis., PMID:32050001
A potential vaccine candidate towards chicken coccidiosis mediated by recombinant Lactobacillus plantarum with surface displayed EtMIC2 protein., PMID:32525007
Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia., PMID:32535112
Immunological evaluation of invasive Lactobacillus plantarum co-expressing EtMIC2 and chicken interleukin-18 against Eimeria tenella., PMID:32715344
NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study., PMID:32779239
Primary Ewing's sarcoma of the lung: a rare case report., PMID:33061150
Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma., PMID:33215253
Analysis of 24 cases of epithelioid glioblastoma: Experience from a tertiary centre of North India., PMID:33341703
Primary diffuse large B cell lymphoma of the lactating left breast. A case report and review of the literature., PMID:33427203
Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells., PMID:34133426
Comparative microsomal proteomics of a model lung cancer cell line NCI-H23 reveals distinct differences between molecular profiles of 3D and 2D cultured cells., PMID:34611477
[Extraskeletal mesenchymal chondrosarcoma in central nerve system: a clinicopathological analysis]., PMID:34619870
CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity., PMID:34627328
Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)., PMID:34638431
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity., PMID:34667115
A minute primary gastric synovial sarcoma with ulcer: a case report., PMID:34895269
CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance., PMID:34934147
High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia., PMID:34958778
Optimization of culture conditions for stable expression of recombinant fc-fused human extracellular CD99 in HEK293T cells., PMID:35988884
Serum peptidome profiles immune response of COVID-19 Vaccine administration., PMID:36091008
Genetic background of anti-Xga producers in Japanese blood donors., PMID:36102098
Cell Adhesion Molecule CD99 in Cancer Immunotherapy., PMID:36214301
Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features., PMID:36689318
Development and application of an indirect ELISA for the serological detection of bovine viral diarrhea virus infection based on the protein E2 antigen., PMID:36849860
Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99., PMID:37298173
A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review., PMID:37735390
FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report., PMID:37776305
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma., PMID:37812652
Expression of NKX2.2 in Non-Ewing Tumors With Round Cell Morphology., PMID:38234938
CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia., PMID:38468825
Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo., PMID:38534214
Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia., PMID:38804310
An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers., PMID:38904760
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia., PMID:39007347
Solitary fibrous tumor of thyroid: Case report., PMID:39138014
Rare mediastinal small round cell melanoma with synovial sarcoma-like immunophenotype: A potential diagnostic pitfall., PMID:39151249
Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatment., PMID:39167846
Immunophenotypic properties association of CLL and ALL patient cells by flow cytometry analysis., PMID:39397873
A comprehensive analysis of the major specificities of anti-human T lymphocyte porcine immunoglobulin (p-ATG)., PMID:39402313
Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies., PMID:39595598
Plasticity of BioPhi-driven humanness optimization in ScFv-CD99 binding affinity validated through AlphaFold, HADDOCK, and MD simulations., PMID:39897056
Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells., PMID:40214906
Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation., PMID:40251154
Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer., PMID:40260248
The Extensive Case Series of 21 CIC::DUX4, 18 BCOR::CCNB3 and 148 Ewing's Sarcomas From a Single Center., PMID:40298239
PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity., PMID:40312493
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma., PMID:40424183
CD99: A Key Regulator in Immune Response and Tumor Microenvironment., PMID:40427525
PMN recruitment in inflammatory lung injury models follows classical transendothelial migration paradigms requiring PECAM-1 and CD99., PMID:40445608
For research use only. Not for human or drug use.
